Kenya will start the vaccination process against Covid-19 Friday at Kenyatta National Hospital following the flagging off of the vaccines at the central vaccine storage site in Kitengela.
According to Health Cabinet Secretary Mutahi Kagwe, the process is being rolled out in all the 47 counties, starting with frontline workers, teachers, security personnel and those over 58 years.
The country received the first batch of 1.02 million doses under the Vaccines Global Access (COVAX) program on Tuesday evening aboard a Qatar Airways flight QR1341.
The consignment was received by top government officials led by Health Cabinet Secretary Mutahi Kagwe, Transport CS James Macharia and CS Margaret Kobia.
Get breaking news on your Mobile as-it-happens. SMS ‘NEWS’ to 20153
Health CS, Senator Mutahi Kagwe early this morning received Astra Zeneca Vaccine consignment at Jomo Kenyatta International Airport, accompanied by Transport CS James Macharia, Health PS Susan Mochache and WHO Representative in Kenya, Dr. Rudi Eggers among others. pic.twitter.com/HEDwRcC249
— Ministry of Health (@MOH_Kenya) March 3, 2021
Kenya now joins other countries in the globe who have began vaccinating their citizens against the virus.
The CS has emphasised on the need to adhere to the Ministry of Health guidelines to help curb the spread of the virus saying that having a vaccine does not mean we have a cure.
He regretted the high rate at which the virus was spreading noting that the positivity rate has moved from 2.8% to 9% since January this year.
Between now and June 30th government is targeting to vaccinate 1.25 million Kenyans in the first phase and 9.6 million in the second phase.
— KBC Channel1 News (@KBCChannel1) March 4, 2021
The country is also planning to import 24 million doses which the World Health Organization (WHO) says the vaccine should cover at least a third of the population.
What you need to know about AstraZeneca Vaccine
Last month, the World Health Organization (WHO) Strategic Advisory Group of Experts on Immunization (SAGE) issued interim recommendations for use of the Oxford/AstraZeneca COVID-19 vaccine (AZD1222).
Those aged above 18 years can be administered the vaccine including those aged 65 and above.
While the vaccine supplies are limited, it is recommended that priority be given to health workers at high risk of exposure and older people.
The vaccination is also recommended for persons with comorbidities (presence of two or more diseases in a patient) that have been identified as increasing the risk of severe COVID-19, including obesity, cardiovascular disease, respiratory disease and diabetes.
Vaccination can be offered to people who have had COVID-19 in the past.
Vaccination can be offered to breastfeeding women if they are part of a group prioritized for vaccination. WHO does not recommend discontinuation of breastfeeding after vaccination.
While pregnancy puts women at higher risk of severe COVID-19, very little data are available to assess vaccine safety in pregnancy.
Who is the vaccine not recommended for?
People with a history of severe allergic reaction to any component of the vaccine should not take it.
The vaccine is not recommended for persons younger than 18 years of age pending the results of further studies.
Tell Us What You Think